A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics
Oral activated charcoal (OAC), a potent adsorbent with no systemic absorption, has been used for centuries to treat poisoning. Recent studies have suggested its potential efficacy in protecting the colonic microbiota against detrimental effects of antibiotics. In a dose-finding safety and feasibilit...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197061/?tool=EBI |
| _version_ | 1818239213607321600 |
|---|---|
| author | Armin Rashidi Sathappan Karuppiah Maryam Ebadi Ryan Shanley Alexander Khoruts Daniel J. Weisdorf Christopher Staley |
| author_facet | Armin Rashidi Sathappan Karuppiah Maryam Ebadi Ryan Shanley Alexander Khoruts Daniel J. Weisdorf Christopher Staley |
| author_sort | Armin Rashidi |
| collection | DOAJ |
| description | Oral activated charcoal (OAC), a potent adsorbent with no systemic absorption, has been used for centuries to treat poisoning. Recent studies have suggested its potential efficacy in protecting the colonic microbiota against detrimental effects of antibiotics. In a dose-finding safety and feasibility clinical trial, 12 healthy volunteers not receiving antibiotics drank 4 different preparations made of 2 possible OAC doses (12 or 25 grams) mixed in 2 possible solutions (water or apple juice), 3 days a week for 2 weeks. Pre- and post-OAC stool samples underwent 16S rRNA gene sequencing and exact amplicon sequence variants were used to characterize the colonic microbiota. The preferred preparation was 12 grams of OAC in apple juice, with excellent safety and tolerability. OAC did not influence the gut microbiota in our healthy volunteers. These findings provide the critical preliminary data for future trials of OAC in patients receiving antibiotics. |
| first_indexed | 2024-12-12T12:53:59Z |
| format | Article |
| id | doaj.art-388eaa45ae8649368619f304942ccf96 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-12T12:53:59Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-388eaa45ae8649368619f304942ccf962022-12-22T00:23:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01176A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibioticsArmin RashidiSathappan KaruppiahMaryam EbadiRyan ShanleyAlexander KhorutsDaniel J. WeisdorfChristopher StaleyOral activated charcoal (OAC), a potent adsorbent with no systemic absorption, has been used for centuries to treat poisoning. Recent studies have suggested its potential efficacy in protecting the colonic microbiota against detrimental effects of antibiotics. In a dose-finding safety and feasibility clinical trial, 12 healthy volunteers not receiving antibiotics drank 4 different preparations made of 2 possible OAC doses (12 or 25 grams) mixed in 2 possible solutions (water or apple juice), 3 days a week for 2 weeks. Pre- and post-OAC stool samples underwent 16S rRNA gene sequencing and exact amplicon sequence variants were used to characterize the colonic microbiota. The preferred preparation was 12 grams of OAC in apple juice, with excellent safety and tolerability. OAC did not influence the gut microbiota in our healthy volunteers. These findings provide the critical preliminary data for future trials of OAC in patients receiving antibiotics.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197061/?tool=EBI |
| spellingShingle | Armin Rashidi Sathappan Karuppiah Maryam Ebadi Ryan Shanley Alexander Khoruts Daniel J. Weisdorf Christopher Staley A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics PLoS ONE |
| title | A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics |
| title_full | A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics |
| title_fullStr | A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics |
| title_full_unstemmed | A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics |
| title_short | A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics |
| title_sort | dose finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197061/?tool=EBI |
| work_keys_str_mv | AT arminrashidi adosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT sathappankaruppiah adosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT maryamebadi adosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT ryanshanley adosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT alexanderkhoruts adosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT danieljweisdorf adosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT christopherstaley adosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT arminrashidi dosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT sathappankaruppiah dosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT maryamebadi dosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT ryanshanley dosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT alexanderkhoruts dosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT danieljweisdorf dosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics AT christopherstaley dosefindingsafetyandfeasibilitystudyoforalactivatedcharcoalanditseffectsonthegutmicrobiotainhealthyvolunteersnotreceivingantibiotics |